BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Completed · Phase 2
Conditions studied: Colorectal Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BMS-247550 in treating patients who have recurrent or metastatic colorectal cancer.
Key facts
- Study ID
- NCT00022477
- Run by
- University of Chicago
- People needed
- 24
- Starts
- 2001-09-01
- Expected to finish
- 2004-12-01
- Last updated by the study team
- 2013-09-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Illinois at Chicago — Chicago, Illinois, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- Louis A. Weiss Memorial Hospital — Chicago, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute — Decatur, Illinois, United States
- Evanston Northwestern Health Care — Evanston, Illinois, United States
- Ingalls Memorial Hospital — Harvey, Illinois, United States
- LaGrange Memorial Hospital — LaGrange, Illinois, United States
- Loyola University Medical Center — Maywood, Illinois, United States
- Lutheran General Cancer Care Center — Park Ridge, Illinois, United States
- Oncology/Hematology Associates of Central Illinois, P.C. — Peoria, Illinois, United States
- Central Illinois Hematology Oncology Center — Springfield, Illinois, United States
- Fort Wayne Medical Oncology and Hematology, Inc. — Fort Wayne, Indiana, United States
- Michiana Hematology/Oncology P.C. — South Bend, Indiana, United States
- Lakeland Medical Center - St. Joseph — Saint Joseph, Michigan, United States
- Albert Einstein Comprehensive Cancer Center — The Bronx, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.